Literature DB >> 14607963

Tolerance to noninherited maternal MHC antigens in mice.

Joachim Andrassy1, Satoshi Kusaka, Ewa Jankowska-Gan, Jose R Torrealba, Lynn D Haynes, Brodie R Marthaler, Robert C Tam, Ben M-W Illigens, Natalie Anosova, Gilles Benichou, William J Burlingham.   

Abstract

The phenomenon of tolerance to noninherited maternal Ags (NIMA) is poorly understood. To analyze the NIMA effect C57BL/6 (H-2(b/b)) males were mated with B6D2F(1) (H-2(b/d)) females, whereby 50% of the offspring are H-2(b/b) mice that have been exposed to maternal H-2(d) alloantigens. Controls were H-2(b/b) offspring of C57BL/6 mothers, either inbred C57BL/6 mice or F(1) backcross mice from breedings with H-2(b/d) fathers. We found that 57% of the H-2(b/b) offspring of semiallogeneic (H-2(b/d)) mothers accepted fully allogeneic DBA/2 (H-2(d/d)) heart grafts for >180 days, while similar transplants were all rejected by day 11 in controls (p < 0.0004). Foster nursing studies showed that both oral and in utero exposure to NIMA are required for this tolerogenic effect. An effect of NIMA was also found to extend the survival of skin grafts from a semiallogeneic donor (p < 0.02). Pretransplant analysis of splenocytes showed a 40-90% reduction of IL-2-, IL-5-, and IFN-gamma-producing T cells responding to H-2(d)-expressing APC in NIMA(d)-exposed vs control mice. Injection of pregnant BALB/c-dm2 (H-2L(d)-negative) female mice i.v. with H-2L(d)(61-80) peptide profoundly suppressed the offspring's indirect pathway alloreactive CD4(+) T cell response to H-2L(d). These results suggest that the natural exposure of the fetus and newborn to maternal cells and/or soluble MHC Ags suppresses NIMA-allospecific T cells of the offspring, predisposing to organ transplant tolerance in adult mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607963     DOI: 10.4049/jimmunol.171.10.5554

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Correlation between post transplant maternal microchimerism and tolerance across MHC barriers in mice.

Authors:  Partha Dutta; William J Burlingham
Journal:  Chimerism       Date:  2011-07-01

2.  Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.

Authors:  Marcus O Muench; Jeng-Chang Chen; Ashley I Beyer; Marina E Fomin
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

3.  Th2 alloimmunity counteracts Th17-type response in the neonatal establishment of lymphoid chimerism.

Authors:  Isabelle Debock; Véronique Flamand
Journal:  Chimerism       Date:  2011 Oct-Dec

4.  Exosomes: The missing link between microchimerism and acquired tolerance?

Authors:  William J Burlingham
Journal:  Chimerism       Date:  2015-12-17

5.  Microchimerism and regulation in living related kidney transplant families.

Authors:  W John Haynes; Ewa Jankowska-Gan; Lynn Haynes; William J Burlingham
Journal:  Chimerism       Date:  2014

Review 6.  Regulatory T cells in pregnancy.

Authors:  Ana Claudia Zenclussen
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

7.  Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Authors:  Masahiro Hirayama; Eiichi Azuma
Journal:  Chimerism       Date:  2011-01

8.  Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes.

Authors:  P G Bronson; P P Ramsay; G Thomson; L F Barcellos
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

9.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

Review 10.  Tolerance to noninherited maternal antigens in mice and humans.

Authors:  Partha Dutta; William J Burlingham
Journal:  Curr Opin Organ Transplant       Date:  2009-08       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.